Influenza A virus H5N6 inactivated vaccine, MF59 adjuvanted (Seqirus)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameInfluenza A virus H5N6 inactivated vaccine, MF59 adjuvanted (Seqirus)
Drug Alias NameaH5N6caH5N6c
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Tract DiseasesInfluenza in BirdsOrthomyxoviridae Infections +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSeqirus
China Registration ClassN/A

Develop Information

Active CompaniesSeqirus
Inactive CompaniesN/A
Active IndicationsInfluenza in BirdsOrthomyxoviridae InfectionsRNA Virus Infections +[6] 
Inactive IndicationsRespiratory Tract DiseasesInfections

Other Information

ATC CodeN/A
Related LinksN/A